Jain Global’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Jain Global’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,600	Closed	-$475K	–	1699
2025 Q1	$475K	Sell	3,600 -3,680	-51%	-$459K	0.01%	561
2024 Q4	$608K	Buy	+7,280	New	+$598K	0.02%	407

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jain Global's ITCI Position: Q2 2025 in Review

Jain Global sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 3,600 shares — an estimated $475K sold.

Jain Global first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $608K in Q4 2024. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Jain Global reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Jain Global sold 3,600 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $475K.
Jain Global first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
Jain Global's Intra-Cellular Therapies Inc. position peaked at $608K in Q4 2024.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Jain Global's 13F filing for Q2 2025, filed 14 Aug 2025.